A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation
Phase of Trial: Phase II
Latest Information Update: 22 Dec 2014
Price : $35 *
At a glance
- Drugs Abametapir (Primary)
- Indications Pediculosis
- Focus Adverse reactions
- Sponsors Hatchtech
- 22 Dec 2014 Last checked against ClinicalTrials.gov record.
- 16 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.